Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
First Claim
Patent Images
1. A method of treating or preventing dementia of Alzheimer'"'"'s type, or other loss of cognitive function caused by reduced neuronal metabolism, comprising administering an effective amount of medium chain triglycerides to a patient in need thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods and compositions for treating or preventing, the occurrence of senile dementia of the Alzheimer'"'"'s type, or other conditions arising from reduced neuronal metabolism and leading to lessened cognitive function are described. In a preferred embodiment the administration of triglycerides or fatty acids with chain lengths between 5 and 12, to said patient at a level to produce an improvement in cognitive ability.
73 Citations
12 Claims
- 1. A method of treating or preventing dementia of Alzheimer'"'"'s type, or other loss of cognitive function caused by reduced neuronal metabolism, comprising administering an effective amount of medium chain triglycerides to a patient in need thereof.
- 10. A method of treating or preventing dementia of Alzheimer'"'"'s type, or other loss of cognitive function caused by reduced neuronal metabolism, comprising coadministering an effective amount of an agent selected from the group consisting of medium chain triglycerides, medium chain fatty acids, and ketone bodies, and L-carnitine or a derivative of L-carnitine to a patient in need thereof.
Specification